(45 days)
Not Found
Not Found
No
The description details standard control mechanisms (manual and servo) based on pre-defined parameters and feedback loops, without mentioning any learning or adaptive algorithms.
Yes
This device is intended to provide a controlled thermal environment and isolation for premature and neonatal infants, which is a therapeutic function for these patients. It also has features like oxygen control and pulse oximetry which can support therapeutic interventions.
No
The device is an infant incubator designed to provide a controlled thermal environment. While it monitors vital signs (like temperature, oxygen, and pulse oximetry), these are for controlling the environment and ensuring the infant's stability, not for diagnosing conditions or diseases.
No
The device description clearly outlines hardware components such as a hooded container, heater, temperature sensors (air and skin), and optional components like an oxygen controller, pulse oximeter, and weight monitor. The performance studies also reference standards related to electrical equipment and safety of baby incubators, indicating a physical device.
Based on the provided information, the V-2100G Advanced Infant Incubator is not an IVD (In Vitro Diagnostic) device.
Here's why:
- IVD devices are used to examine specimens derived from the human body. The V-2100G is a device that provides a controlled environment for infants. It does not analyze blood, urine, tissue, or any other biological samples.
- The intended use and device description clearly state its function is to provide a controlled thermal environment and isolation for infants. This is a life support and environmental control device, not a diagnostic tool.
- The performance studies listed are related to electrical safety and incubator-specific standards. They do not involve the analysis of biological specimens or diagnostic accuracy.
Therefore, the V-2100G Advanced Infant Incubator falls under the category of medical devices used for patient care and support, not in vitro diagnostics.
N/A
Intended Use / Indications for Use
The V-2100G Advanced Infant Incubator is a hooded container that is intended to provide a controlled thermal environment and isolation from ambient air for premature and neonatal infants. The V-2100G is not intended for the transport of infants.
Product codes (comma separated list FDA assigned to the subject device)
FMZ
Device Description
The V-2100G Infant Incubator provides standard functions to control the incubator temperature, either by manual (air) or servo (baby) control, and air humidity. The incubator also provides an external communication function that allows data to be exported to the user's PC for evaluation and storage. In addition, the incubator provides the following optional functions: oxygen controller, pulse oximeter, and weight monitor.
The temperature in the incubator can be controlled using one of two modes: manual control mode or servo control mode. In manual control mode, the incubator air temperature is controlled to maintain the desired infant temperature. The air temperature is initially set based on the user's training and experience and is then adjusted based on the infant's needs and clinical status. In the servo control mode, a skin temperature probe is attached to the infant and is monitored by the incubator controller. The heater output is controlled to maintain the infant's skin temperature at a set value. Changes to the heater output are made gradually, so as to minimize temperature overshoot and infant stress.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Not Found
Indicated Patient Age Range
premature and neonatal infants.
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Performance testing for the V-2100G Infant Incubator has been conducted for functional and design verification. This testing demonstrates that the V-2100G Infant Incubator is in compliance with the following recognized consensus standards;
- IEC 60601-1 (1988-12) Medical Electrical Equipment, Part 1: General Requirements for Safety, Amendment 1 (1991-11), Amendment 2 (1995-03)
- EN 60601-1-2 (1993) Medical Electrical Equipment, Part 1: General Requirements for Safety, Electromagnetic Compatibility-Requirements and Tests
- IEC 60601-2-19 (1990-12) Medical Electrical Equipment, Part 2: Particular Requirements for Safety o f Baby Incubators, Amendment 1 (1996-10)
- ISO 7767 (1997) Oxygen Monitors for Monitoring Patient Breathing Mixtures -. Safety Requirements
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
Not Found
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 880.5400 Neonatal incubator.
(a)
Identification. A neonatal incubator is a device consisting of a rigid boxlike enclosure in which an infant may be kept in a controlled environment for medical care. The device may include an AC-powered heater, a fan to circulate the warmed air, a container for water to add humidity, a control valve through which oxygen may be added, and access ports for nursing care.(b)
Classification. Class II (performance standards).
0
Ko21809
510(k) Summary
for
V-2100G Advanced Infant Incubator
1. SPONSOR
Atom Medical Corporation 3-18-15, Hongo Bunkyo-Ku Tokyo, 113-0033 Japan
Contact Person: Hiroshi Tanaka, Manager, Quality Regulatory Department Telephone: 03-3815-2311
Date Prepared: May 31, 2002
DEVICE NAME 2.
| Proprietary Name: | V-2100G Advanced Infant Incubator |
|---|---|
| Common/Usual Name: | Infant Incubator |
| Classification Name: | Neonatal Incubator |
నే. PREDICATE DEVICES
The V-2100G Advanced Infant Incubator is substantially equivalent to the following devices:
- Air Shields Isolette® Infant Incubators and Accessories .
- . Ohmeda Ohio Care Plus Infant Incubators and Accessories
4. INTENDED USE
The V-2100G Advanced Infant Incubator is a hooded container that is intended to provide a controlled thermal environment and isolation from ambient air for premature and neonatal infants. The V-2100G is not intended for the transport of infants.
1
5. DEVICE DESCRIPTION
The V-2100G Infant Incubator provides standard functions to control the incubator temperature, either by manual (air) or servo (baby) control, and air humidity. The incubator also provides an external communication function that allows data to be exported to the user's PC for evaluation and storage. In addition, the incubator provides the following optional functions: oxygen controller, pulse oximeter, and weight monitor.
The temperature in the incubator can be controlled using one of two modes: manual control mode or servo control mode. In manual control mode, the incubator air temperature is controlled to maintain the desired infant temperature. The air temperature is initially set based on the user's training and experience and is then adjusted based on the infant's needs and clinical status. In the servo control mode, a skin temperature probe is attached to the infant and is monitored by the incubator controller. The heater output is controlled to maintain the infant's skin temperature at a set value. Changes to the heater output are made gradually, so as to minimize temperature overshoot and infant stress.
6. SUBSTANTIAL EQUIVALENCE
Atom Medical Corporation makes the claim of substantial equivalence based on intended use, design, operational and technological characteristics, and principles of operation. Atom Medical Corporation believes that the descriptive information, performance test summaries, and certificates of compliance provided in this premarket notification are precise enough to demonstrate the substantial equivalence of the V-2100G Infant Incubator to the identified predicate devices. The V-2100G and the predicate devices are all intended to provide a controlled environment for neonates. The V-2100G and the predicate devices all operate in both manual and servo modes for temperature control. All devices also offer humidity control as a standard function and a variety of optional functions including oxygen supply and control, a weight monitor, and an RS-232 communications module. All devices have similar displays, alarms, and user controls.
7. PERFORMANCE TESTING
Performance testing for the V-2100G Infant Incubator has been conducted for functional and design verification. This testing demonstrates that the V-2100G Infant Incubator is in compliance with the following recognized consensus standards;
2
IEC 60601-1 (1988-12) Medical Electrical Equipment, Part 1: General Requirements for Safety, Amendment 1 (1991-11), Amendment 2 (1995-03)
- . EN 60601-1-2 (1993) Medical Electrical Equipment, Part 1: General Requirements for Safety, Electromagnetic Compatibility-Requirements and Tests
- IEC 60601-2-19 (1990-12) Medical Electrical Equipment, Part 2: Particular Requirements for Safety o f Baby Incubators, Amendment 1 (1996-10)
- ISO 7767 (1997) Oxygen Monitors for Monitoring Patient Breathing Mixtures -. Safety Requirements
3
DEPARTMENT OF HEALTH & HUMAN SERVICES
Image /page/3/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a circular seal with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" arranged around the perimeter. Inside the circle is a stylized graphic of three human profiles facing to the right, with the profiles overlapping each other.
Public Health Service
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
JUL 1 8 2002
Atom Medical Corporation C/O Ms. Sheila Hemeon-Heyer, Esq. Senior Staff Consultant Medical Device Consultants, Incorporated 49 Plain Street North Attleboro, Massachusetts 02760
Re: K021809
Trade/Device Name: V-2100G Advanced Infant Incubator Regulation Number: 880.5400 Regulation Name: Neonatal Incubator Regulatory Class: II Product Code: FMZ Dated: May 31, 2002 Received: June 03, 2002
Dear Ms. Hemeon-Hever:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA). it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
4
Page 2 .- Ms. Sheila Hemeon-Heyer
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (OS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801 and additionally 21 CFR Part 809.10 for in vitro diagnostic devices), please contact the Office of Compliance at (301) 594-4618. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers. International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/dsma/dsmamain.html
Sincerely yours,
Time Director Division of Anesthesiology, General Hospital, Infection Control and Dental Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
5
510(k) Number (if known):
Device Name: V-2100G Advanced Infant Incubator
Indications For Use:
The V-2100G Advanced Infant Incubator is a hooded container that is intended to provide a controlled thermal environment and isolation from ambient air for premature and neonatal infants. The V-2100G is not intended for the transport of infants.
(PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NECESSARY)
Concurrence of CDRH, Office of Device Evaluation (ODE)
Patricia Cirincione
(Division Sign-Off) (Division of Dental, Infection Control, and General Hospital Devices 510(k) Number -
| Prescription Use | ✓ |
|---|---|
| (Per 21 CFR 801.109) |
OR
Over-The-Counter Use
(Optional Format 1-2-96)
Atom Medical Corporation May 31, 2002 V-2100G Infant Incubator - Abbreviated 510(k)
Page viii